World Hepatitis Day 2021

by | Jul 28, 2021 | Blog, CDC, Healthcare, HIV, Treatment, Vaccine, WHO

Today, July 28, is observed as World Hepatitis Day. July 28 is the birthday of Dr. Baruch Blumberg (1925-2011). He first discovered the hepatitis B virus in 1967. In 1969, he developed the first vaccine for hepatitis B, which is still being used today. There are five main strains of the virus: A, B, C, D, and E. Combines, hepatitis B and C are the most common that results in 1.1 million deaths and over 3 million new infections per year. 2 

World Hepatitis Day initiates opportunities to educate individuals about the different strands of hepatitis, a variety of efforts to combat hepatitis around the world, and actions an individual can take to prevent hepatitis infections.1 

World Hepatitis Day helps raise awareness of viral hepatitis or inflammation of the liver that causes hepatocellular cancer and severe liver disease; hepatitis impacts more than 354 million individuals worldwide. While deaths from tuberculosis are declining, deaths from hepatitis are only increasing. 1  

With an individual dying every 30 seconds from a hepatitis-related illness, even in a COVID-19 pandemic, it is important to act on viral hepatitis. This year’s theme is “Hepatitis Can’t Wait”. According to the World Health Organization, or WHO, a hepatitis-free future is achievable. WHO and the CDC are asking every country to work together to eliminate viral hepatitis as a public threat by the year 2030. According to WHO, this is extremely achievable, especially since 42% of children across the world has access to the birth dose of hepatitis B vaccine. 2  

WHO and CDC collaborate to help countries experiencing higher rates of infection to control, prevent, and eliminate viral hepatitis. To further eliminate hepatitis infections, WHO and CDC help countries build capacities for treatment, testing, surveillance, care, and assists with the development and implementation of control and elimination programs. 1 Recently, WHO and CDC have helped Tanzania, Uzbekistan, and Pakistan eradicate hepatitis. 2  

EMMA International has worked hand-in-hand with several organizations across the life-science industry to help decrease hepatitis. Through this, we have also had the privilege of being a part of a global community of healthcare providers working every day to eradicate hepatitis. 

EMMA International is available 24/7 to support your quality and regulatory needs. Contact us at 248-987-4497 or email at info@emmainternational.com today! 

1World Hepatitis day 2021. (2021). Who.int. https://www.who.int/campaigns/world-hepatitis-day/2021 

2World Hepatitis Day is July 28th. (2021). https://www.cdc.gov/hepatitis/awareness/worldhep day.htm 

Abby McVay

Abby McVay

Research Analyst- Ms. McVay is EMMA International’s Research Analyst. She has experience in technical writing and clinical trials in many life science industries. She has experience with many different elements of quality and regulatory compliance. Ms. McVay holds a Bachelor of Science in Psychology from Manchester University as well as a Master of Science in Industrial and Organizational Psychology from Angelo State University.

More Resources

De Novo Classification

De Novo Classification

A device can be registered for the De Novo pathway if there is evidence of the safety and effectiveness of the device and there is not a previously legally marketed predicate device1. When determining if your device can go through the De Novo process there are two pathways available to determine the device classification.
Abbreviated 510k submission

Abbreviated 510k submission

There are three types of 510K, Premarket Notifications, which can be submitted to the Food and Drug Administration (FDA) traditional, abbreviated, and special. Abbreviated and Special 510K submissions can be utilized when the submissions meet the certain factors presented by the FDA. When submitting an abbreviated 510K the submission must include the elements that are identified in 21CFR 807.87 for the information required in a premarket notification submission.
Is your product a medical device?

Is your product a medical device?

Many marketed products are classified as medical devices and you would not even know it. Medical devices range from latex gloves and tongue depressors to respirators and heart valves. To determine if the product is considered a medical device by the Food and Drug Administration (FDA) you will need to analyze if your product meets the definition of a medical device per the Food, Drug, and Cosmetic Act1.

Ready to learn more about working with us?

Pin It on Pinterest

Share This